Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
出版年份 2019 全文链接
标题
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
作者
关键词
-
出版物
Frontiers in Microbiology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-01-09
DOI
10.3389/fmicb.2018.03257
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction
- (2018) Wakana Saso et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Human bile acid transporter ASBT ( SLC10A2 ) forms functional non-covalent homodimers and higher order oligomers
- (2018) Paresh P. Chothe et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures
- (2018) Mei Song et al. JOURNAL OF VIROLOGY
- Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide
- (2018) Manabu Kaneko et al. Scientific Reports
- Perspectives and limitations for nucleo(t)side analogs in future HBV therapies
- (2018) Massimo Levrero et al. Current Opinion in Virology
- Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
- (2018) Thomas Tu et al. Current Opinion in Virology
- Small molecule induced oligomerization, clustering and clathrin-independent endocytosis of the dopamine transporter
- (2018) Tatiana Sorkina et al. eLife
- A new class of hepatitis B and D virus entry inhibitors, proanthocyanidin and its analogs, that directly act on the viral large surface proteins
- (2017) Senko Tsukuda et al. HEPATOLOGY
- Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread
- (2017) P. Karayiannis Hepatology International
- Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity
- (2017) Satomi Shimura et al. JOURNAL OF HEPATOLOGY
- Novel targets for hepatitis B virus therapy
- (2017) Barbara Testoni et al. LIVER INTERNATIONAL
- Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP
- (2017) Joanne M. Donkers et al. Scientific Reports
- Chloroquine, a FDA-approved Drug, Prevents Zika Virus Infection and its Associated Congenital Microcephaly in Mice
- (2017) Chunfeng Li et al. EBioMedicine
- Functional association of cellular microtubules with viral capsid assembly supports efficient hepatitis B virus replication
- (2017) Masashi Iwamoto et al. Scientific Reports
- Fungus-Derived Neoechinulin B as a Novel Antagonist of Liver X Receptor, Identified by Chemical Genetics Using a Hepatitis C Virus Cell Culture System
- (2016) Syo Nakajima et al. JOURNAL OF VIROLOGY
- Novel Robust in Vitro Hepatitis B Virus Infection Model Using Fresh Human Hepatocytes Isolated from Humanized Mice
- (2015) Yuji Ishida et al. AMERICAN JOURNAL OF PATHOLOGY
- Irbesartan, an FDA approved drug for hypertension and diabetic nephropathy, is a potent inhibitor for hepatitis B virus entry by disturbing Na+-dependent taurocholate cotransporting polypeptide activity
- (2015) Xue-jun Wang et al. ANTIVIRAL RESEARCH
- The FDA approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide
- (2015) Chunkyu Ko et al. ANTIVIRAL THERAPY
- Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure
- (2015) Mirjam B Zeisel et al. GUT
- Present and future therapies of hepatitis B: From discovery to cure
- (2015) T. Jake Liang et al. HEPATOLOGY
- A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide
- (2015) Manabu Kaneko et al. JOURNAL OF VIROLOGY
- Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP)
- (2015) Isabel Veloso Alves Pereira et al. PLoS One
- Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
- (2014) Matthieu Blanchet et al. ANTIVIRAL RESEARCH
- Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line
- (2014) Naoki Ogura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression
- (2014) Senko Tsukuda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes
- (2014) Alexander König et al. JOURNAL OF HEPATOLOGY
- Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide
- (2014) H. Yan et al. JOURNAL OF VIROLOGY
- Arbidol inhibits viral entry by interfering with clathrin-dependent trafficking
- (2013) Julie Blaising et al. ANTIVIRAL RESEARCH
- Inhibition of influenza virus internalization by (−)-epigallocatechin-3-gallate
- (2013) Meehyein Kim et al. ANTIVIRAL RESEARCH
- Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives
- (2013) Syo Nakajima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP
- (2013) Masashi Iwamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking
- (2013) Julie Blaising et al. CELLULAR MICROBIOLOGY
- Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
- (2013) Yi Ni et al. GASTROENTEROLOGY
- Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)
- (2013) Koichi Watashi et al. HEPATOLOGY
- Phase 1 study of efatutazone, a novel oral peroxisome proliferator-activated receptor gamma agonist, in combination with FOLFIRI as second-line therapy in patients with metastatic colorectal cancer
- (2013) Yoshito Komatsu et al. INVESTIGATIONAL NEW DRUGS
- Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
- (2013) Koichi Watashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial
- (2013) R. C. Smallridge et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
- (2013) Shirin Nkongolo et al. JOURNAL OF HEPATOLOGY
- The ins and outs of hepatitis C virus entry and assembly
- (2013) Brett D. Lindenbach et al. NATURE REVIEWS MICROBIOLOGY
- Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes
- (2012) Julie Lucifora et al. ANTIVIRAL RESEARCH
- Silymarin for HCV infection
- (2012) Stephen J Polyak et al. ANTIVIRAL THERAPY
- A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
- (2012) Camille Sureau et al. HEPATOLOGY
- Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity
- (2012) J.J. Ott et al. VACCINE
- Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
- (2012) Huan Yan et al. eLife
- Homo- and hetero-dimeric architecture of the human liver Na+-dependent taurocholate co-transporting protein
- (2011) Ingrid T. G. W. Bijsmans et al. BIOCHEMICAL JOURNAL
- Hepatocellular carcinoma and gene profiling: Back from perspective to reality
- (2011) Alain Braillon HEPATOLOGY
- Differential In Vitro Effects of Intravenous versus Oral Formulations of Silibinin on the HCV Life Cycle and Inflammation
- (2011) Jessica Wagoner et al. PLoS One
- Multiple effects of silymarin on the hepatitis C virus lifecycle
- (2010) Jessica Wagoner et al. HEPATOLOGY
- Exon-skipping Splice Variants of Excitatory Amino Acid Transporter-2 (EAAT2) Form Heteromeric Complexes with Full-length EAAT2
- (2010) Florian M. Gebhardt et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C
- (2010) Sandra Beinhardt et al. JOURNAL OF HEPATOLOGY
- Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cells
- (2010) Mohsin Khan et al. JOURNAL OF MEDICAL VIROLOGY
- Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients With Chronic Hepatitis C
- (2009) Roy L. Hawke et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
- Glycine Transporter Dimers
- (2008) Ingo Bartholomäus et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oligomeric Structure and Minimal Functional Unit of the Electrogenic Sodium Bicarbonate Cotransporter NBCe1-A
- (2008) Liyo Kao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started